NCT02989818 Multi-center Evaluation of the Clinical Utility of ESD in the Western Population
| NCT ID | NCT02989818 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Endoscopic Submucosal Dissection |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2016-03 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2016-03 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this multi-center study is to prospectively document the clinical utility of ESD.
Eligibility Criteria
Inclusion Criteria: * a. Age 18 years or older. * b. Scheduled to undergo ESD as part of their standard of care. Exclusion Criteria: * a. Any contraindication to performing endoscopy. * b. Participation in another research protocol that could interfere or influence the outcome measures of the present study. * c. Patient is unable/unwilling to provide informed consent.
Contact & Investigator
Peter Draganov, MD
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT02989818 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Endoscopic Submucosal Dissection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02989818 currently recruiting?
Yes, NCT02989818 is actively recruiting participants. Contact the research team at peter.draganov@medicine.ufl.edu for enrollment information.
Where is the NCT02989818 trial being conducted?
This trial is being conducted at Gainesville, United States, Boston, United States, Houston, United States.
Who is sponsoring the NCT02989818 clinical trial?
NCT02989818 is sponsored by University of Florida. The principal investigator is Peter Draganov, MD at University of Florida. The trial plans to enroll 300 participants.